What Techdow USA does

Techdow USA Inc. is a US-based, privately held pharmaceutical company headquartered at 2050 Cabot Boulevard West, Suite 200 in Langhorne, Pennsylvania. It develops, manufactures, and sells FDA-approved critical-care injectable medications for hospital, clinical, and dialysis-center settings. Its portfolio consists of three core product lines: Heparin Sodium Injection USP (an anticoagulant offered across nine vial presentations from 1,000 to 50,000 USP Units/mL, with the 30,000 USP Units/30mL vial noted as the most widely used SKU for dialysis centers); Enoxaparin Sodium, a preservative-free generic version of Lovenox® delivered in prefilled syringes across seven dosage strengths (30mg to 150mg); and Fosaprepitant Injection USP (150mg lyophilized vials), an antiemetic for chemotherapy-induced nausea and vomiting launched in collaboration with CTTQ Pharma in August 2023. The company emphasizes vertical integration in raw materials as the basis for competitive pricing and supply reliability, including a direct-purchase contingency channel introduced during the 2022 heparin shortage.

The company operates a sales-led go-to-market model targeting hospital pharmacy buyers and dialysis operators through a customer operations team and a purchasing portal hosted by R&S Solutions. Its Business Development organization is described as a global group of experts, and commercial reach is reinforced by active participation in ASHP, CPHI, DCAT, NACDS, NPPA, IDN Summits, and other major industry events. Marketing is concentrated in earned media (Business Wire press releases, Fierce Pharma sponsored content) and a corporate website that surfaces product information, partnership opportunities, and adverse-event reporting. Techdow USA is a subsidiary operating within the Hepalink network (referenced alongside 'Hepalink USA, Inc.' in adverse-event reporting), with Hepalink acting as a strategic parent and a global leader in pharmaceutical heparin API. The company holds NABP Accredited Drug Distributor status and reports no AI, software, or platform products.

Name

Techdow USA

Legal name

Techdow USA Inc.

Website

https://techdowusa.com

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Techdow USA is a private, FDA-approved pharmaceutical company in Langhorne, Pennsylvania that manufactures and sells critical-care injectable medications — Heparin Sodium, generic Enoxaparin (Lovenox®), and Fosaprepitant — to US hospitals, clinical settings, and dialysis centers.

Ownership category

akta.pro rank

Product category

Generic Injectable Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412)

akta.pro primary industry

Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)

Keywords

• Generic injectables
• Anticoagulant manufacturing
• Hospital pharmaceuticals
• Heparin sodium production
• Enoxaparin prefilled syringes

Headquarters

HQ city

Langhorne

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Pharmaceutical Product Sales: Techdow USA generates revenue through the development, manufacture, and sale of FDA approved critical pharmaceutical products. Their product portfolio includes Heparin Sodium Injection (multiple strengths), Enoxaparin Sodium Prefilled Syringes, and Fosaprepitant Injection. Products are sold to hospital and clinical settings including dialysis centers. The company is vertically integrated in raw materials, enabling competitive pricing and reliable supply.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Techdow USA develops, manufactures, and sells FDA-approved critical injectable pharmaceuticals for hospital and clinical settings. Its product portfolio consists of Heparin Sodium Injection USP (multiple strengths/vials), Enoxaparin Sodium prefilled syringes (generic Lovenox), and Fosaprepitant Injection (antiemetic). The company is vertically integrated in raw materials, enabling it to deliver hard-to-source products at competitive prices and offer special-access supply during shortages.

Product overview

Techdow USA is a vertically integrated pharmaceutical company that develops, manufactures, and sells FDA-approved critical-care medications for hospital and clinical settings. The company's product portfolio consists of three core product lines: Heparin Sodium Injection, USP (a widely-used anticoagulant with nine strength variants ranging from 1,000 to 50,000 USP Units/mL in various vial sizes); Enoxaparin Sodium (a generic version of Lovenox® delivered as preservative-free prefilled syringes in seven dosage strengths from 30mg to 150mg); and Fosaprepitant Injection, USP (an antiemetic for chemotherapy-induced nausea launched via collaboration with CTTQ Pharma). The company emphasizes its vertically integrated raw materials capabilities that enable competitive pricing and reliable supply, including special access options during critical market shortages.

Differentiator

Problem solved

Functional benefit

Products and services

• Heparin Sodium Injection, USP FDA-approved anticoagulant medication available in multiple strengths (1,000 to 50,000 USP Units/mL) across nine SKU/vial formats for hospital and clinical settings. Includes 5,000 USP Units/1mL, 2,000 USP Units/2mL, 10,000 USP Units/10mL, 1,000 USP Units/1mL, 20,000 USP Units/1mL, 30,000 USP Units/30mL (most widely used for dialysis centers), 50,000 USP Units/5mL, and 50,000 USP Units/10mL presentations.
• Enoxaparin Sodium (Generic Lovenox) Prefilled Syringes FDA-approved generic version of Lovenox (Enoxaparin Sodium – Preservative Free) delivered as prefilled syringes in seven dosage strengths (30mg to 150mg) for anticoagulation therapy in hospital and clinical settings.
• Fosaprepitant Injection, USP FDA-approved injectable antiemetic medication for prevention of chemotherapy-induced nausea and vomiting. Available as 150mg lyophilized vials, launched in collaboration with CTTQ Pharma for hospital and clinical use.

Quantifiable outcome

• Successfully launched FDA approved generic Enoxaparin Sodium (Lovenox) in prefilled syringes, March 2023
• +1 more outcomes

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• CTTQ PharmacoreStrategic or Co-development Partner · 22 August 2023Techdow USA and CTTQ Pharma announced a collaboration agreement and launched Fosaprepitant for Injection. This partnership enables Techdow USA to expand its product portfolio with an additional specialty pharmaceutical product for hospital use.

Scale indicators1 record

Recent moves5 records

Expansion highlights5 records

Direct peers

• Meitheal Pharmaceuticals: Meitheal is a smaller, growth-oriented US generic injectables company focused on critical-care and oncology-support sterile products for hospital customers, directly comparable to Techdow USA's positioning and channel strategy.
• Amphastar Pharmaceuticals: Amphastar is a specialty generic injectable manufacturer with leading positions in enoxaparin sodium (generic Lovenox), heparin sodium, and other critical-care injectables. It is the most direct US competitor to Techdow USA across the same hospital/clinical channels and product categories.
• Fresenius Kabi: Fresenius Kabi is a global supplier of generic injectable pharmaceuticals, including heparin and enoxaparin products sold to US hospitals. It competes head-to-head with Techdow USA in sterile hospital injectables and shares the same vertically-integrated supplier profile.
• ANI Pharmaceuticals: ANI is a US specialty generics company focused on hospital and institutional injectable products, including anticoagulants and limited-competition sterile injectables. It is a similarly-sized, similarly-focused direct competitor.
• Hikma Pharmaceuticals: Hikma is a leading US supplier of generic injectable medicines (heparin, oncology injectables, anaesthesia) with a direct hospital sales model that mirrors Techdow USA's channel strategy and target buyer profile.
• Dr. Reddy's Laboratories: Dr. Reddy's is a vertically integrated generic injectables player selling into US hospitals, with strong positions in oncology-support injectables and other sterile hospital products comparable to Techdow USA's portfolio.

Broad incumbents

• Sandoz: Sandoz is the world's largest generics company by revenue and is the originator's authorized enoxaparin competitor, with broad US hospital injectable coverage. It is a broader incumbent versus Techdow USA's niche focus, but a direct head-to-head on enoxaparin.
• Baxter International: Baxter supplies a broad range of sterile injectable and hospital products globally, including heparin. As a larger incumbent with diversified offerings, it overlaps with Techdow USA in critical-care injectables while serving many other hospital categories.
• Teva Pharmaceutical Industries: Teva is a major US generics supplier with an injectable portfolio that includes anticoagulants; it competes with Techdow USA in critical-care hospital injectables while operating across many more therapeutic areas.
• Pfizer (Hospira Injectables): Pfizer's Hospital business (built on the acquired Hospira franchise) is one of the largest US injectable suppliers, including heparin and enoxaparin. As a broad incumbent it competes across Techdow USA's full portfolio in hospitals and dialysis.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/techdow-usa-inc

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Techdow USA